Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    3:00 PM - 4:30 PM Central Time
    26S55: Abstracts: Pain in Rheumatic Disease Including Fibromyalgia
    Location: S105
    Abstract Moderator: Titilola Falasinnu, PhD – Stanford School of Medicine
    Abstract Moderator: Mohamad Bittar, MD, MS – Oregon Health and Science University
     CE: 0.00
  • Sunday, Oct 26th
    3:00 PM - 4:30 PM Central Time
    26S56: It's Not All in Your Head: Neuroimmune Mechanisms of Pain
    Location: W181A-C
    Moderator: Caroline Jefferies, PhD – Cedars-Sinai Medical Center
    Moderator: Anne-Marie Malfait, MD – Rush University Medical Center
    Session Coordinator: Polly Ferguson, MD – University of Iowa Carver College of Medicine
     CE: 1.50
  • Sunday, Oct 26th
    3:00 PM - 3:15 PM Central Time
    0813: Impact of Tirzepatide on Musculoskeletal Pain and High-Risk Analgesic Use Among Non-Diabetic Patients with Overweight or Obesity: A Propensity Score-Matched, Active Comparator, New User Study
    Location: S105
    Presenting Author: Gregory Challener, MD – Massachusetts General Hospital
  • Sunday, Oct 26th
    3:00 PM - 3:30 PM Central Time
    Neuronal Control of Skin Inflammation
    Location: W181A-C
    Speaker: Dan Kaplan, MD, PhD – University of Pittsburgh
  • Sunday, Oct 26th
    3:15 PM - 3:30 PM Central Time
    0814: Pain Patterns in a Multicenter Randomized Trial of Early RA – Link Between Initially Sustained Joint Inflammation and Subsequent Non-inflammatory Pain Outcomes
    Location: S105
    Presenting Author: Tor Olofsson, MD, PhD – Lund University, Skåne University Hosptital
  • Sunday, Oct 26th
    3:30 PM - 3:45 PM Central Time
    0815: Neuropathic-like Pain Characteristics Predict Worse Pain Outcomes in Early Rheumatoid Arthritis: a Prospective Cohort Study with Embedded Neuroimaging Evaluation
    Location: S105
    Presenting Author: Anushka Irani, PhD, MBBCH – Mayo Clinic
  • Sunday, Oct 26th
    3:30 PM - 4:00 PM Central Time
    Deciphering the Neuroimmune Interactome of Inflammatory Pain
    Location: W181A-C
    Speaker: Aakanksha Jain, PhD – Boston Children's Hospital
  • Sunday, Oct 26th
    3:45 PM - 4:00 PM Central Time
    0816: Persistent Pain Despite Inflammatory Control in RA: A Pooled Analysis of 7 RCTs
    Location: S105
    Presenting Author: Andreas Kerschbaumer, MD, PhD – Medical University of Vienna / Stanford University
  • Sunday, Oct 26th
    4:00 PM - 4:15 PM Central Time
    0817: More than 40% of Older Adults with Rheumatic Diseases Are Prescribed Opioid Medications
    Location: S105
    Presenting Author: Christine Anastasiou, MD – Stanford University
  • Sunday, Oct 26th
    4:00 PM - 4:30 PM Central Time
    Pain Mechanisms in the Pathogenesis of Osteoarthritis
    Location: W181A-C
    Speaker: Rachel Miller, PhD, BS – Rush University Medical Center
  • Sunday, Oct 26th
    4:15 PM - 4:30 PM Central Time
    0818: Risk of Cardiovascular Events is Higher in Pregabalin Users Versus Duloxetine: A Cohort Study Among Veterans with Chronic Musculoskeletal Pain
    Location: S105
    Presenting Author: Sachalee Campbell, MBBS, MPH – University of Miami/ Jackson Health System
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Pain in Rheumatic Disease Including Fibromyalgia Poster
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1243: Broad Cytokine Dysregulation in Fibromyalgia Patients: A Pilot Immune Profiling Study
    Location: Hall F1
    Abstract Poster Presenter: Robert Katz, MD – Rush University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1228: Transcending barriers to pain care in rural America: a pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain
    Location: Hall F1
    Abstract Poster Presenter: Emily Holladay, MPH – University of Alabama at Birmingham
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1237: Six Month Clinical Outcomes of a Digital Therapeutic Augmented Virtual Care Clinic for Fibromyalgia Management
    Location: Hall F1
    Abstract Poster Presenter: Mike Rosenbluth, PhD – Swing Therapeutics
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1226: Preliminary Findings in the Validation of the Modified Pain and Symptom Assessment Tool in Juvenile Fibromyalgia Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Daniella Schocken, MD (she/her/hers) – Children's Mercy Kansas City
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1246: Myo Vs. Myo-fascial Injection for Myofascial Trigger Points. Is There Really a Difference? A Randomized Controlled Trial
    Location: Hall F1
    Abstract Poster Presenter: seda yildiz, MD – izmir sehir hastanesi
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1222: Efficacy of Fasinumab, An Anti-Nerve Growth Factor Monoclonal Antibody, in Managing Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Ahmed Abouelella, MBBCH – College of Human Medicine, Benha University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1229: Extent versus impact: Sex-specific burden of chronic pain in older adults
    Location: Hall F1
    Abstract Poster Presenter: Gillian Fennell, PhD (she/her/hers) – Boston University Medical
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1230: Chronic pain phenotypes in older adults: Identifying patterns of musculoskeletal pain and associated burden
    Location: Hall F1
    Abstract Poster Presenter: Gillian Fennell, PhD (she/her/hers) – Boston University Medical
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1247: Relation of Measures of Pain Sensitization to Widespread Pain
    Location: Hall F1
    Abstract Poster Presenter: Tuhina Neogi, MD, PhD – Boston University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1233: Synovial Joint Transcriptomic Differences in Individuals with Knee Osteoarthritis and Neuropathic Pain Symptomology
    Location: Hall F1
    Abstract Poster Presenter: Joseph Lesnak, PhD, DPT – University of Texas at Dallas
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1241: Beyond Pain Severity in Psoriatic Arthritis: Pain Catastrophizing Independently Impacts Disease Burden and Quality of Life
    Location: Hall F1
    Abstract Poster Presenter: Rebecca Haberman, MD – NYU Langone Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1234: Serum Antibodies Against Glial Fibrillary Acidic Protein in Fibromyalgia: A Proof-of-Concept Study
    Location: Hall F1
    Abstract Poster Presenter: Laura Aline Martinez-Martinez, PhD – Rheumatology Department at National Institute of Cardiology Ignacio Chávez
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1239: JAK inhibition appears to alter clinical and neurobiological markers of nociplastic pain in rheumatoid arthritis: a 7T MRI Brain study
    Location: Hall F1
    Abstract Poster Presenter: Neil Basu, MD, PhD – University of Glasgow
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1238: Pain Is Associated with An Increased Risk of Frailty in Veterans with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Nadine El-ayache, DO, PhD – VA Puget Sound Health Care System & University of Washington
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1225: Association Between Anxiety and Tender Swollen Joint Difference in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Clarice Lin, MD – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1227: The Composition of Circulating Immune Cells is Associated with Nociplastic Pain in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Deborah Winter, PhD – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1223: Pain and Fibromyalgia Across Autoimmune and Inflammatory Diseases in the AMP AIM Cohort
    Location: Hall F1
    Abstract Poster Presenter: Alexis Ogdie, MD – University of Pennsylvania
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1240: Serum Olink Proteomics Identifies Novel Mediators of Pain in Lupus Nephritis Patients Without Extrarenal Clinical Activity
    Location: Hall F1
    Abstract Poster Presenter: Philip Carlucci, MD – New York University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1232: Does Social Support Reduce Bodily Pain among African American Women with SLE?: Findings from a Randomized Controlled Trial
    Location: Hall F1
    Abstract Poster Presenter: Jerik Leung, MPH – Emory University, Rollins School of Public Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1235: Demystifying Pain in patients with Lupus: How much is it Lupus and How much is it Other Stuff?
    Location: Hall F1
    Abstract Poster Presenter: Meenakshi Jolly, MD – Rush University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1221: Oxytocin pathway gene BST1 polymorphism rs4273468 genotype GG is negatively associated with Fibromyalgia
    Location: Hall F1
    Abstract Poster Presenter: Able Lawrence, MD, DM – SGPGIMS, Lucknow
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1236: Vestibulocortical Stimulation via Caloric Irrigation in Nociplastic Disease: Therapeutic Effects on Pain, Autonomic Functioning & Quality of Life Measures
    Location: Hall F1
    Abstract Poster Presenter: Michael Kaplan, MD – Icahn School of Medicine at Mount Sinai
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1245: Efficacy And Safety of Low-dose Naltrexone In Fibromyalgia: An Updated Systematic Review And Meta-Analysis of Randomized Controlled Trials (RCTs)
    Location: Hall F1
    Abstract Poster Presenter: Rubab Rizwan, MD – VBMC,Nuvance Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1231: TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, Demonstrates Pain Reduction and Favorable Tolerability in Patients with Fibromyalgia
    Location: Hall F1
    Abstract Poster Presenter: Gregory Sullivan, MD – Tonix Pharmaceuticals Inc
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1242: Relax the Body: Dual-Agent Nighttime Therapy for Fibromyalgia: Symptom Reduction Using Tricyclic Antidepressants and Muscle Relaxants
    Location: Hall F1
    Abstract Poster Presenter: Robert Katz, MD – Rush University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1224: Comparative Effectiveness of Duloxetine versus Pregabalin in Fibromyalgia: A Large-Scale, Real-World Study Across 300,000 Patients
    Location: Hall F1
    Abstract Poster Presenter: Chukwuemelie Okeke, MBBS – Maimonides Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1244: PACFiND: Co-Designing Principles To Inform Reconfiguration Of Fibromyalgia Care Across Health Systems
    Location: Hall F1
    Abstract Poster Presenter: Rosemary Hollick, BSc, MBChB, PhD, FRCP – University of Aberdeen